Real‐world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C‐Registry

201973 citationsJournal Article

Authors

Thomas Berg · University Hospital Leipzig

Uwe Naumann · Leibniz-Centre General Linguistics

Albrecht Stoehr · Institute for Interdisciplinary Medicine

C. Sick · University of Bremen

Christine John · Total (Germany)

G Teuber · Cardiovascular Center Frankfurt

Willibold Schiffelholz

Abstract

Glecaprevir/pibrentasvir was highly effective and well tolerated under real-world conditions. Clinical trial number: DRKS00009717 (German Clinical Trials Register, DRKS).

Topics & Keywords

Hepatitis C virus research HIV/AIDS drug development and treatment Systemic Lupus Erythematosus Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Alimentary Pharmacology & Therapeutics

Volume 49, Issue 8, pp. 1052-1059

DOI: 10.1111/apt.15222

Field-Weighted Citation Impact: 7.70